Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Sep;19(9):1139-43.
doi: 10.1007/BF00965147.

Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine

M H Baf  1 , M N Subhash, K M Lakshmana, B S Rao
Affiliations

Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine

M H Baf et al. Neurochem Res. 1994 Sep.

Abstract

Carbamazepine (25 mg/kg body weight) was administered intraperitoneally to adult male Wistar rats for 45 days and norepinephrine (NE), dopamine (DA) and serotonin (5-HT) levels were simultaneously assayed in discrete brain regions by high performance liquid chromatographic (HPLC) method. Experimental rats displayed no behavioral abnormalities. Body and brain weights were not significantly different from control group of rats. After exposure it was observed that norepinephrine levels were elevated in motor cortex (P < 0.01) and cerebellum (P < 0.05), while dopamine levels were decreased in these two regions (P < 0.001, P < 0.05). However, dopamine levels were increased in hippocampus (P < 0.01). Serotonin levels were significantly decreased in motor cortex (P < 0.001) and hypothalamus (P < 0.001) but increased in striatum-accumbens (P < 0.001) and brainstem (P < 0.001). These results suggest that carbamazepine may mediate its anticonvulsant effect by differential alterations of monoamine levels in discrete brain regions particularly in motor cortex and cerebellum.

PubMed Disclaimer

References

    1. Neurology. 1972 Nov;22(11):1151-9 - PubMed
    1. Neuroscience. 1981;6(6):1069-80 - PubMed
    1. Arch Int Pharmacodyn Ther. 1976 Mar;220(1):125-39 - PubMed
    1. Epilepsia. 1992 Mar-Apr;33(2):263-70 - PubMed
    1. J Pharmacol Exp Ther. 1984 Oct;231(1):166-72 - PubMed